 | • レポートコード：QYR9ST04823 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、子宮内膜癌の世界市場について調査・分析し、子宮内膜癌の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（子宮摘出術、放射線、ホルモン療法、化学療法）、用途別（病院、診療所、婦人科センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の子宮内膜癌市場動向 ・主要企業別マーケットシェア ・子宮内膜癌の種類別市場規模2014-2019 （子宮摘出術、放射線、ホルモン療法、化学療法） ・子宮内膜癌の用途別市場規模2014-2019 （病院、診療所、婦人科センター、その他） ・子宮内膜癌の北米市場：主要企業・種類別/用途別市場規模 ・子宮内膜癌のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・子宮内膜癌の中国市場：主要企業・種類別/用途別市場規模 ・子宮内膜癌の日本国内市場：主要企業・種類別/用途別市場規模 ・子宮内膜癌の東南アジア市場：主要企業・種類別/用途別市場規模 ・子宮内膜癌のインド市場：主要企業・種類別/用途別市場規模 ・子宮内膜癌の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Johnson & Johnson、Boston Scientific、GE、Karl Storz、Koninklijke Philips、Celgene、Lupin、LiNA Medical、Bayer AG、Cooper Surgical、Hologic） ・子宮内膜癌の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Other symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.The endometrial cancer market is dominated by North America owing to the rising prevalence of breast cancer.
Asia-Pacific was projected to be the fastest growing region for the global endometrial cancer market in 2017. The market is expected to witness growth owing to the rising prevalence of diabetes in women, changing lifestyle, and growing obesity within the female population.
In 2018, the global Endometrial Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Endometrial Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Endometrial Cancer development in United States, Europe and China.
The key players covered in this study
Pfizer
Johnson & Johnson
Boston Scientific
GE
Karl Storz
Koninklijke Philips
Celgene
Lupin
LiNA Medical
Bayer AG
Cooper Surgical
Hologic
Market segment by Type, the product can be split into
Hysterectomy Techniques
Radiation
Hormone Therapy
Chemotherapy
Market segment by Application, split into
Hospitals
Clinics
Gynecology Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Endometrial Cancer status, future forecast, growth opportunity, key market and key players.
To present the Endometrial Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Endometrial Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Endometrial Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Hysterectomy Techniques
1.4.3 Radiation
1.4.4 Hormone Therapy
1.4.5 Chemotherapy
1.5 Market by Application
1.5.1 Global Endometrial Cancer Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Gynecology Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Endometrial Cancer Market Size
2.2 Endometrial Cancer Growth Trends by Regions
2.2.1 Endometrial Cancer Market Size by Regions (2014-2025)
2.2.2 Endometrial Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Endometrial Cancer Market Size by Manufacturers
3.1.1 Global Endometrial Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Endometrial Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Endometrial Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Endometrial Cancer Key Players Head office and Area Served
3.3 Key Players Endometrial Cancer Product/Solution/Service
3.4 Date of Enter into Endometrial Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Endometrial Cancer Market Size by Type (2014-2019)
4.2 Global Endometrial Cancer Market Size by Application (2014-2019)
5 United States
5.1 United States Endometrial Cancer Market Size (2014-2019)
5.2 Endometrial Cancer Key Players in United States
5.3 United States Endometrial Cancer Market Size by Type
5.4 United States Endometrial Cancer Market Size by Application
6 Europe
6.1 Europe Endometrial Cancer Market Size (2014-2019)
6.2 Endometrial Cancer Key Players in Europe
6.3 Europe Endometrial Cancer Market Size by Type
6.4 Europe Endometrial Cancer Market Size by Application
7 China
7.1 China Endometrial Cancer Market Size (2014-2019)
7.2 Endometrial Cancer Key Players in China
7.3 China Endometrial Cancer Market Size by Type
7.4 China Endometrial Cancer Market Size by Application
8 Japan
8.1 Japan Endometrial Cancer Market Size (2014-2019)
8.2 Endometrial Cancer Key Players in Japan
8.3 Japan Endometrial Cancer Market Size by Type
8.4 Japan Endometrial Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Endometrial Cancer Market Size (2014-2019)
9.2 Endometrial Cancer Key Players in Southeast Asia
9.3 Southeast Asia Endometrial Cancer Market Size by Type
9.4 Southeast Asia Endometrial Cancer Market Size by Application
10 India
10.1 India Endometrial Cancer Market Size (2014-2019)
10.2 Endometrial Cancer Key Players in India
10.3 India Endometrial Cancer Market Size by Type
10.4 India Endometrial Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Endometrial Cancer Market Size (2014-2019)
11.2 Endometrial Cancer Key Players in Central & South America
11.3 Central & South America Endometrial Cancer Market Size by Type
11.4 Central & South America Endometrial Cancer Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Endometrial Cancer Introduction
12.1.4 Pfizer Revenue in Endometrial Cancer Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Endometrial Cancer Introduction
12.2.4 Johnson & Johnson Revenue in Endometrial Cancer Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Boston Scientific
12.3.1 Boston Scientific Company Details
12.3.2 Company Description and Business Overview
12.3.3 Endometrial Cancer Introduction
12.3.4 Boston Scientific Revenue in Endometrial Cancer Business (2014-2019)
12.3.5 Boston Scientific Recent Development
12.4 GE
12.4.1 GE Company Details
12.4.2 Company Description and Business Overview
12.4.3 Endometrial Cancer Introduction
12.4.4 GE Revenue in Endometrial Cancer Business (2014-2019)
12.4.5 GE Recent Development
12.5 Karl Storz
12.5.1 Karl Storz Company Details
12.5.2 Company Description and Business Overview
12.5.3 Endometrial Cancer Introduction
12.5.4 Karl Storz Revenue in Endometrial Cancer Business (2014-2019)
12.5.5 Karl Storz Recent Development
12.6 Koninklijke Philips
12.6.1 Koninklijke Philips Company Details
12.6.2 Company Description and Business Overview
12.6.3 Endometrial Cancer Introduction
12.6.4 Koninklijke Philips Revenue in Endometrial Cancer Business (2014-2019)
12.6.5 Koninklijke Philips Recent Development
12.7 Celgene
12.7.1 Celgene Company Details
12.7.2 Company Description and Business Overview
12.7.3 Endometrial Cancer Introduction
12.7.4 Celgene Revenue in Endometrial Cancer Business (2014-2019)
12.7.5 Celgene Recent Development
12.8 Lupin
12.8.1 Lupin Company Details
12.8.2 Company Description and Business Overview
12.8.3 Endometrial Cancer Introduction
12.8.4 Lupin Revenue in Endometrial Cancer Business (2014-2019)
12.8.5 Lupin Recent Development
12.9 LiNA Medical
12.9.1 LiNA Medical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Endometrial Cancer Introduction
12.9.4 LiNA Medical Revenue in Endometrial Cancer Business (2014-2019)
12.9.5 LiNA Medical Recent Development
12.10 Bayer AG
12.10.1 Bayer AG Company Details
12.10.2 Company Description and Business Overview
12.10.3 Endometrial Cancer Introduction
12.10.4 Bayer AG Revenue in Endometrial Cancer Business (2014-2019)
12.10.5 Bayer AG Recent Development
12.11 Cooper Surgical
12.12 Hologic
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Endometrial Cancer Key Market Segments
Table Key Players Endometrial Cancer Covered
Table Global Endometrial Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Endometrial Cancer Market Size Market Share by Type 2014-2025
Figure Hysterectomy Techniques Figures
Table Key Players of Hysterectomy Techniques
Figure Radiation Figures
Table Key Players of Radiation
Figure Hormone Therapy Figures
Table Key Players of Hormone Therapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Table Global Endometrial Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Gynecology Centers Case Studies
Figure Others Case Studies
Figure Endometrial Cancer Report Years Considered
Table Global Endometrial Cancer Market Size 2014-2025 (Million US$)
Figure Global Endometrial Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Endometrial Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Endometrial Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Endometrial Cancer Market Share by Regions 2014-2019
Figure Global Endometrial Cancer Market Share by Regions 2014-2019
Figure Global Endometrial Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Endometrial Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Endometrial Cancer Market Share by Manufacturers (2014-2019)
Figure Global Endometrial Cancer Market Share by Manufacturers in 2018
Table Global Endometrial Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Endometrial Cancer Product/Solution/Service
Table Date of Enter into Endometrial Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Endometrial Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Endometrial Cancer Market Size Share by Type (2014-2019)
Figure Global Endometrial Cancer Market Size Market Share by Type (2014-2019)
Table Global Endometrial Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Endometrial Cancer Market Size Share by Application (2014-2019)
Figure Global Endometrial Cancer Market Size Market Share by Application (2014-2019)
Figure Global Endometrial Cancer Revenue Market Share by Application in 2018
Figure United States Endometrial Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Endometrial Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Endometrial Cancer Market Share (2018-2019)
Table United States Endometrial Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Endometrial Cancer Market Share by Type (2014-2019)
Table United States Endometrial Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Endometrial Cancer Market Share by Application (2014-2019)
Figure Europe Endometrial Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Endometrial Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Endometrial Cancer Market Share (2018-2019)
Table Europe Endometrial Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Endometrial Cancer Market Share by Type (2014-2019)
Table Europe Endometrial Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Endometrial Cancer Market Share by Application (2014-2019)
Figure China Endometrial Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Endometrial Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Endometrial Cancer Market Share (2018-2019)
Table China Endometrial Cancer Market Size by Type (2014-20189) (Million US$)
Table China Endometrial Cancer Market Share by Type (2014-2019)
Table China Endometrial Cancer Market Size by Application (2014-2019) (Million US$)
Table China Endometrial Cancer Market Share by Application (2014-2019)
Figure Japan Endometrial Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Endometrial Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Endometrial Cancer Market Share (2018-2019)
Table Japan Endometrial Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Endometrial Cancer Market Share by Type (2014-2019)
Table Japan Endometrial Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Endometrial Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Endometrial Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Endometrial Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Endometrial Cancer Market Share (2018-2019)
Table Southeast Asia Endometrial Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Endometrial Cancer Market Share by Type (2014-2019)
Table Southeast Asia Endometrial Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Endometrial Cancer Market Share by Application (2014-2019)
Figure India Endometrial Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Endometrial Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Endometrial Cancer Market Share (2018-2019)
Table India Endometrial Cancer Market Size by Type (2014-2019) (Million US$)
Table India Endometrial Cancer Market Share by Type (2014-2019)
Table India Endometrial Cancer Market Size by Application (2014-2019) (Million US$)
Table India Endometrial Cancer Market Share by Application (2014-2019)
Figure Central & South America Endometrial Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Endometrial Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Endometrial Cancer Market Share (2018-2019)
Table Central & South America Endometrial Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Endometrial Cancer Market Share by Type (2014-2019)
Table Central & South America Endometrial Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Endometrial Cancer Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Endometrial Cancer Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Endometrial Cancer Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Endometrial Cancer Business (2014-2019)(Million US$)
Figure Boston Scientific Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table Boston Scientific Recent Development
Table GE Company Details
Table GE Revenue in Endometrial Cancer Business (2014-2019)(Million US$)
Figure GE Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table GE Recent Development
Table Karl Storz Company Details
Table Karl Storz Revenue in Endometrial Cancer Business (2014-2019)(Million US$)
Figure Karl Storz Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table Karl Storz Recent Development
Table Koninklijke Philips Company Details
Table Koninklijke Philips Revenue in Endometrial Cancer Business (2014-2019)(Million US$)
Figure Koninklijke Philips Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table Koninklijke Philips Recent Development
Table Celgene Company Details
Table Celgene Revenue in Endometrial Cancer Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table Celgene Recent Development
Table Lupin Company Details
Table Lupin Revenue in Endometrial Cancer Business (2014-2019)(Million US$)
Figure Lupin Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table Lupin Recent Development
Table LiNA Medical Company Details
Table LiNA Medical Revenue in Endometrial Cancer Business (2014-2019)(Million US$)
Figure LiNA Medical Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table LiNA Medical Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Endometrial Cancer Business (2014-2019)(Million US$)
Figure Bayer AG Revenue Growth Rate in Endometrial Cancer Business (2014-2019)
Table Bayer AG Recent Development
Table Cooper Surgical Company Details
Table Hologic Company Details
Table Global Endometrial Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Endometrial Cancer Market Size Share by Regions (2019-2025)
Figure Global Endometrial Cancer Market Size Share by Regions in 2025
Figure United States Endometrial Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Endometrial Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Endometrial Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Endometrial Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Endometrial Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Endometrial Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Endometrial Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Endometrial Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Endometrial Cancer Market Size by Product (2019-2025)
Figure Global Endometrial Cancer Market Size by Product in 2025
Table Global Endometrial Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Endometrial Cancer Market Size by Application (2019-2025)
Figure Global Endometrial Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
子宮内膜がんの治療の世界市場：インサイト・予測 The global Endometrial Cancer Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Endometrial Cancer Treatment market based o…- ホルモン不応性前立腺癌(HRPCA)の世界市場：市場規模・現状・予測 Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 子宮内膜アブレーションの世界市場：市場規模・現状・予測 Endometrial ablation is a non-invasive procedure which results in destruction of or ablation of the outermost lining of uterus called endometrium.The endometrial ablation is essentially used in the treatment of abnormal uterine bleeding. In addition, prolonged abnormal uterine bleeding can result in…
- ホルモン不応性前立腺癌(HRPCA)の世界市場：インサイト・予測 Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 膵臓癌治療の世界市場：市場規模・現状・予測 Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …